Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-008313)

Filing Details

Accession Number:: 0001415889-24-008313
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-18 17:37:30
Reporting Period:: 2023-01-09

Accepted Time:: 2024-03-18 17:37:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614740	Christopher Peetz	C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-09	5,159	$20.62	91,953	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	208,570	Indirect	By The Peetz Family Trust

Footnotes

Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.
7,000 shares held indirectly by the reporting person were inadvertently reported on prior Form 4 filings as direct holdings. The reporting person's holdings on this Form 4 have been adjusted accordingly.